Compare Bristol-Myers Squibb Co (BMY) vs Byrna Technologies Inc (BYRN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bristol-Myers Squibb Co vs Byrna Technologies Inc — how do they compare? Bristol-Myers Squibb Co trades at $63.7 (market cap $129.94B), while Byrna Technologies Inc trades at $4.68 (market cap $106.74M). The key difference: Bristol-Myers Squibb Co is far larger — about 1217.4× Byrna Technologies Inc's market cap, and Bristol-Myers Squibb Co pays a 3.96% dividend while Byrna Technologies Inc pays none. Which is the better fit depends on your goals.
| BMY | BYRN | |
|---|---|---|
Market Cap | $129.94B | $106.74M |
Sector | Health | Technology |
52-Week High | $65.89 | $27.63 |
52-Week Low | $42.60 | $3.18 |
Enterprise Value | $163.92B | $98.35M |
Dividend Yield | 3.96% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →About Byrna Technologies Inc
Byrna Technologies specializes in less-lethal personal security devices. It develops and manufactures innovative handheld launchers and projectiles designed for self-defense, law enforcement, and private security use.
Read more on BYRN →
